About: CODO: an Ontology for collection and analysis of COviD-19 data   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Ontology, within Data Space : covidontheweb.inria.fr associated with source document(s)

AttributesValues
type
has creation date
  • 2020-04-27
has modification date
  • 2022-04-16
  • 2023-03-31
  • 2023-07-11
has title
  • CODO: an Ontology for collection and analysis of COviD-19 data
described by
has creator
  • Biswanath Dutta
  • Debanjali Bain
has publisher
  • Indian Statistical Institute
abstract
  • This specification describes CODO, an integrated ontological data model, a formal Ontology for collection and analysis of COVID-19 and related data. The Introduction section further provides the overall scope of the ontology and its usage. It is designed using W3C's RDF technology.
has license
  • https://creativecommons.org/licenses/by/4.0/
versionIRI
https://w3id.org/mod#competencyQuestion
  • CQ 1: What mutations were discovered in patient p1's genomic testing results? CQ 2: Which patient's test result revealed the N501Y mutation? CQ 3: Which SARS-CoV-2 variant has patient p1 been diagnosed with? CQ 4: Which sequencing method was used in the genome sequencing test for patient p1? CQ 5: Who has been diagnosed as an Omicron patient? CQ 6: Which patients' nasopharyngeal swabs have been collected? CQ 7: A person's genomic sequence report reveals that the spike protein has a del69-70 mutation. Which variants might there be? CQ 8: What are the characteristic mutations found in the test result of a person (p2) diagnosed with the B.1.1.529 variant? CQ 9: What are all the substitution mutations that occurred in B.1.1.7? CQ 10: What mutations are detected in Delta? CQ 11: Where and when was the initial B.1.351 variant discovered? CQ 12: What structural proteins are present in SARS-CoV-2? CQ 13. Which therapeutics are recommended for COVID-19 patients with specific underlying health conditions? CQ 14. What are the potential adverse effects of specific COVID-19 drugs? CQ 15. Identify the drug interactions that may occur with a particular COVID-19 therapeutic. CQ 16. What are the risk factors associated with severe COVID-19 infection? CQ 17. How does the choice of COVID-19 therapeutics vary based on patient characteristics? CQ 18. Which drugs should be avoided due to known interactions with commonly prescribed COVID-19 medications?
prov:preferredNamespacePrefix
  • codo
prov:preferredNamespaceURI
  • https://w3id.org/codo
http://w3id.org/mod#browsingUI
  • https://w3id.org/codo
is topic of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software